Skip to content
Home/Companies/HealthTech/OncoVerse
ON

OncoVerse

HealthTech·United States·Exited 2017·Held 1yr

OncoVerse is a HealthTech company, headquartered in United States.

Entry
2016
Hold
1yr
Exit
2017
Est. EV
–

Who owns OncoVerse?

OncoVerse was owned by EMV Capital through EMV Capital Evergreen Fund (2012 vintage) from 2016 to 2017, exited via Trade Sale.

Hand-verified · updated 2026-07-17

EMV Capital
Investor
EMV Capital
EMV Capital Evergreen Fund · 2012 · VC

Key facts

HQUnited States
SectorHealthTech
StatusAcquired
Exit Type
Trade Sale
Buyer
–
MOIC
–
Exit Year
2017

More from EMV Capital Evergreen Fund

Other portfolio companies in the same fund.

AMR Bio
Active
BiotechUK· 2025
Dname-iT
Active
SoftwareUK· 2023
DeepTech Recycling
Active
ClimateTechUK· 2022
Ventive
Active
TMTUK· 2022
Cetromed
Active
BiotechUK· 2021
Martlet Capital
Active
FinancialsUK· 2021

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

Paladin
Active
Ring CapitalFrance
Access Infinity
Active
CBPE CapitalUK· 2026
Axomove
Active
INCO VENTURESFrance· 2026
Brightheart
Active
Odyssée VentureFrance· 2026
CertHub
Active
D11Z. VenturesGermany· 2026
Dermascan
Active
Ring CapitalFrance· 2026
Data refreshed weekly · Sourced from public filings